Thermo Fisher Scientific: Purpose-Built Solutions for Pharmaceutical Challenges By R&D Editors | May 31, 2007Thermo Fisher Scientific: Purpose-Built Solutions for Pharmaceutical Challenges Thermo Fisher Scientific: Purpose-Built Solutions for Pharmaceutical Challenges
This week in AI research: Latest Insilico Medicine drug enters the clinic, a $0.55/M token model R1 rivals OpenAI’s $60 flagship, and more
R&D Market Pulse: $29B energy mega-merger, new CHIPS Act hub at ASU, and more AI restrictions on China